早发型胎儿生长受限的结局在计算机胎心率分析联合静脉导管多普勒时最佳:来自欧洲脐动脉与胎儿血流试验的见解
欧洲多中心随机试验纳入26-32周腹围小于第10百分位且脐动脉搏动指数大于第95百分位的胎儿生长受限孕妇,随机分为计算机胎心监护、早期或晚期静脉导管多普勒三组监测分娩方案。511例中围产期及2年结局均优于预期,存活者中晚期静脉导管组2年神经发育正常比例高于单独计算机胎心监护组。
要点
- 早发型胎儿生长受限孕妇中72%(362/503)合并高血压疾病。
- 存活者中晚期静脉导管组2年神经发育正常133/144(95%),高于计算机胎心监护组111/131(85%)。
- 32周前分娩者中38%(118/310)因安全网标准分娩,晚期静脉导管组占52%(55/106)。
核心结论
- 所有随机组的围产期和2年结局均优于预期,存活者中基于晚期静脉导管变化决定分娩者2年神经发育结局最佳。
- 鉴于安全网标准分娩率高,作者认为基于晚期静脉导管变化和异常计算机胎心率变异性决定分娩似乎是审慎的。
- 作者指出没有理由仅基于大脑多普勒变化决定分娩,并注意到大多数早发型胎儿生长受限孕妇发生高血压。
研究设计与样本
- 欧洲多中心随机试验(欧洲脐动脉与胎儿血流试验),旨在确定早发型胎儿生长受限的分娩触发标准。
- 纳入26-32周腹围小于第10百分位且脐动脉搏动指数大于第95百分位的孕妇,随机分为3种监测和分娩方案。
- 3组分别为基于计算机胎心监护的胎心率变异性、早期静脉导管多普勒变化和晚期静脉导管多普勒变化。
- 基于胎心率异常或脐动脉多普勒变化的安全网标准无论随机分组均强制分娩。
- 主要结局为2岁时神经发育正常。
主要发现
- 511例孕妇随机中,362/503(72%)合并高血压疾病。
- 463/503(92%)胎儿存活,已知结局者中脑性瘫痪发生6/443(1%)。
- 所有孕妇中随机分组间结局无差异;存活者中晚期静脉导管组正常结局133/144(95%),高于计算机胎心监护组111/131(85%)。
- 310例32周前分娩的婴儿中118例(38%)因安全网标准分娩:晚期静脉导管组55/106(52%)、早期静脉导管组37/99(37%)、计算机胎心监护组26/105(25%)。
- 校正孕周后大脑中动脉阻抗较高与新生儿无严重疾病存活相关(比值比1.24;95%置信区间1.02-1.52),与2岁时无神经发育损害存活相关(比值比1.33;95%置信区间1.03-1.72),但出生体重和孕周是更重要的决定因素。
关键数值与推荐
- 早发型胎儿生长受限定义:26-32周腹围小于第10百分位且脐动脉搏动指数大于第95百分位。
临床怎么用
- 作者认为基于晚期静脉导管变化和异常计算机胎心率变异性决定分娩似乎是审慎的。
- 作者指出没有理由仅基于大脑多普勒变化决定分娩。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Early-onset fetal growth restriction represents a particular dilemma in clinical management balancing the risk of iatrogenic prematurity with waiting for the fetus to gain more maturity, while being exposed to the risk of intrauterine death or the sequelae of acidosis. OBJECTIVE: The Trial of Umbilical and Fetal Flow in Europe was a European, multicenter, randomized trial aimed to determine according to which criteria delivery should be triggered in early fetal growth restriction. We present the key findings of the primary and secondary analyses. STUDY DESIGN: Women with fetal abdominal circumference <10th percentile and umbilical pulsatility index >95th percentile between 26-32 weeks were randomized to 1 of 3 monitoring and delivery protocols. These were: fetal heart rate variability based on computerized cardiotocography; and early or late ductus venosus Doppler changes. A safety net based on fetal heart rate abnormalities or umbilical Doppler changes mandated delivery irrespective of randomized group. The primary outcome was normal neurodevelopmental outcome at 2 years. RESULTS: Among 511 women randomized, 362/503 (72%) had associated hypertensive conditions. In all, 463/503 (92%) of fetuses survived and cerebral palsy occurred in 6/443 (1%) with known outcome. Among all women there was no difference in outcome based on randomized group; however, of survivors, significantly more fetuses randomized to the late ductus venosus group had a normal outcome (133/144; 95%) than those randomized to computerized cardiotocography alone (111/131; 85%). In 118/310 (38%) of babies delivered <32 weeks, the indication was safety-net criteria: 55/106 (52%) in late ductus venosus, 37/99 (37%) in early ductus venosus, and 26/105 (25%) in computerized cardiotocography groups. Higher middle cerebral artery impedance adjusted for gestation was associated with neonatal survival without severe morbidity (odds ratio, 1.24; 95% confidence interval, 1.02-1.52) and infant survival without neurodevelopmental impairment at 2 years (odds ratio, 1.33; 95% confidence interval, 1.03-1.72) although birthweight and gestational age were more important determinants. CONCLUSION: Perinatal and 2-year outcome was better than expected in all randomized groups. Among survivors, 2-year neurodevelopmental outcome was best in those randomized to delivery based on late ductus venosus changes. Given a high rate of delivery based on the safety-net criteria, deciding delivery based on late ductus venosus changes and abnormal computerized fetal heart rate variability seems prudent. There is no rationale for delivery based on cerebral Doppler changes alone. Of note, most women with early-onset fetal growth restriction develop hypertension.
引用
- Frusca T, Todros T, Lees C, et al. Outcome in early-onset fetal growth restriction is best combining computerized fetal heart rate analysis with ductus venosus Doppler: insights from the Trial of Umbilical and Fetal Flow in Europe. Am J Obstet Gynecol. 2018. PMID: 29422211. doi:10.1016/j.ajog.2017.12.226
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。